🇺🇸 FDA

Intelligence Platform

Patents

Browse 262 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8722863

Solid state forms of fidaxomycin and processes for preparation thereof

Teva Pharmaceutical Works Ltd. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8715710

Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

Heron Therapeutics, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697097

Stable solid preparations

Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697094

Stable solid preparations

Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8674108

Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653103

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-m

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653094

Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1

LEXICON PHARMACEUTICALS, INC. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637079

Solid preparation comprising alogliptin and pioglitazone

Takeda Pharmaceutical Company Limited · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8632808

Taste-masking solid preparation of pioglitazone

Takeda Pharmaceutical Company Limited · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623894

Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-c

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614252

Crystalline solid rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597666

Compressed solid dosage form manufacturing process well-suited for use with drugs of low a

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8519002

Colchicine solid complex; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507534

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-m

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507687

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-m

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8486450

Method of producing solid preparation disintegrating in the oral cavity

Takeda Pharmaceutical Company Limited · Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481552

Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8476281

Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyr

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8471029

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461172

Solid forms and process for preparing

Corcept Therapeutics Incorporated · Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8436014

Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(

Vertex Pharmaceuticals Incorporated · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420885

Determining the capability of a test compound to affect solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8410274

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8389727

Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Tr

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted